13 вынікі
FIELD OF THE INVENTION
The present invention is concerned with novel indole and dihydroindole derivatives, their manufacture and their use as medicaments.
BACKGROUND OF THE INVENTION
2,3-oxidosqualene-lanosterol cyclase (EC 5.4.99.) is required for the biosynthesis of cholesterol, ergosterol and
FIELD OF THE INVENTION
The present invention is concerned with novel aminocyclohexanol derivatives, their manufacture and their use as 2,3-oxidosqualene-lanosterol cyclase inhibiting medicaments.
BACKGROUND OF THE INVENTION
Causal risk factors that directly promote the development of coronary and
FIELD OF THE INVENTION
The present invention is concerned with novel aminocyclohexanol derivatives, their manufacture and their use as 2,3-oxidosqualene-lanosterol cyclase inhibiting medicaments.
BACKGROUND OF THE INVENTION
Causal risk factors that directly promote the development of coronary and
FIELD OF THE INVENTION
The present invention is concerned with novel heteroaromates, their manufacture and their use as medicaments.
BACKGROUND OF THE INVENTION
The compounds of the present invention inhibit 2,3-oxidosqualene-lanosterol cyclase (EC 5.4.99.) which is required for the biosynthesis of
FIELD OF THE INVENTION
The present invention is concerned with novel heteroaromates, their manufacture and their use as medicaments.
BACKGROUND OF THE INVENTION
The compounds of the present invention inhibit 2,3-oxidosqualene-lanosterol cyclase (EC 5.4.99.) which is required for the biosynthesis of
FIELD OF THE INVENTION
The present invention is concerned with novel dihydroindole and tetrahydroquinoline derivatives, their manufacture and their use as medicaments.
BACKGROUND OF THE INVENTION
2,3-oxidosqualene-lanosterol cyclase (EC 5.4.99.) is required for the biosynthesis of cholesterol,
FIELD OF THE INVENTION
The present invention is concerned with novel dihydroindole and-tetrahydroquinoline derivatives, their manufacture and their use as medicaments.
BACKGROUND OF THE INVENTION
2,3-oxidosqualene-lanosterol cyclase (EC 5.4.99.) is required for the biosynthesis of cholesterol,
FIELD OF THE INVENTION
The present invention is related to novel hydroxyalkylamide derivatives of formula (I) ##STR2##
wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, W, X, m and n are as defined herein below, as well as to a process for the manufacture of a compound of formula (I), a pharmaceutical
BACKGROUND
The molecule 6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one, also known as Ciclopirox, is a commercially available topical antifungal agent. Ciclopirox has been used to treat superficial mycoses and Tinea versicolor. However, ciclopirox has a very poor solubility in aqueous fluids,
BACKGROUND
The molecule 6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one, also known as Ciclopirox, is a commercially available topical antifungal agent. Ciclopirox has been used to treat superficial mycoses and Tinea versicolor. However, ciclopirox has a very poor solubility in aqueous fluids,
FIELD OF THE INVENTION
The present invention is concerned with novel aminoalkylamide substituted cyclohexyl derivatives, their manufacture and their use as medicaments. In particular, the invention relates to compounds of the formula I
##STR00002## wherein
FIELD OF THE INVENTION
The present invention is concerned with novel aniline derivatives, their manufacture and their use as medicaments. The compounds of the present invention inhibit 2,3-oxidosqualene-lanosterol cyclase (EC5.4.99.) which is required for the biosynthesis of cholesterol, ergosterol
BACKGROUND
The molecule 6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one, also known as Ciclopirox, is a commercially available antifungal agent as an olamine salt. Ciclopirox olamine has been used to treat superficial mycoses and Tinea versicolor following topical application to the skin. Following